Mutation in cytochrome b gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activation

Journal of Medical Genetics

Volumn 53, Issue 2, 2016, Pages 113-122

  Cordero, Mario D ^a,b   Alcocer Gómez, Elísabet ^c,d   Marín Aguilar, Fabiola ^a   Rybkina, Tatyana ^c   Cotán, David ^c,d   Pérez Pulido, Antonio ^c   Alvarez Suarez, José Miguel ^e   Battino, Maurizio ^f   Sánchez Alcazar, José Antonio ^c,d   Carrión, Angel M ^c   Culic, Ognjen ^g   Navarro Pando, José M ^h   Bullón, Pedro ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSIDAD DE LAS AMÉRICAS   (Ecuador)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h Cátedra de Reproducción y Genética Humana del Instituto para el Estudio de la Biología de la Reproducción Humana INEBIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CRYOPYRIN; CYTOCHROME B; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOCHONDRIAL DNA; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; VALINE; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYBRID; DNA SEQUENCE; FEMALE; FIBROMYALGIA; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOCHONDRIAL GENE; MITOCHONDRIAL GENOME; OXIDATIVE STRESS; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SKIN FIBROBLAST; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; MITOCHONDRION; MUTATION; PATHOLOGY;

ADULT; CARRIER PROTEINS; CYTOCHROMES B; DNA, MITOCHONDRIAL; FEMALE; FIBROMYALGIA; HUMANS; INFLAMMASOMES; MALE; MIDDLE AGED; MITOCHONDRIA; MUTATION; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PEDIGREE;

EID: 84958949607     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2015-103392     Document Type: Article

References (56)

1. Greaves LC, Reeve AK, Taylor RW, Turnbull DM. Mitochondrial DNA and disease. J Pathol 2012;226:274-86.
2. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Wong LJ, Cohen BH, Naviaux RK. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16-37.
3. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552 (Pt 2):335-441.
4. Ozgocmen S, Ozyurt H, Sogut S, Akyol O. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 2006;26:585-97.
5. Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 2005;25:188-90.
6. Cordero MD, De Miguel M, Moreno-Fernández AM, Carmona López IM, Garrido Maraver J, Cotán D, Gómez Izquierdo L, Bonal P, Campa F, Bullon P, Navas P, Sánchez Alcázar JA. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implication in the pathogenesis of the disease. Arthritis Res Ther 2010;12:R17.
7. Gerdle B, Forsgren MF, Bengtsson A, Leinhard OD, Sören B, Karlsson A, Brandejsky V, Lund E, Lundberg P. Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients-a 31P-MRS study. Eur J Pain 2013;17:1205-15.
8. Miyamae T, Seki M, Naga T, Uchino S, Asazuma H, Yoshida T, Iizuka Y, Kikuchi M, Imagawa T, Natsumeda Y, Yokota S, Yamamoto Y. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep 2013;18:12-19.
9. Cordero MD, Alcocer-Gómez E, de Miguel M, Culic O, Carrión AM, Alvarez-Suarez JM, Bullón P, Battino M, Fernández-Rodríguez A, Sánchez-Alcazar JA. Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia? Antioxid Redox Signal 2013;19:1356-61.
10. Bazzichi L, Giannaccini G, Betti L, Fabbrini L, Schmid L, Palego L, Giacomelli C, Rossi A, Giusti L, De Feo F, Giuliano T, Mascia G, Bombardieri S, Lucacchini A. ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem 2008;41:1084-90.
11. Cordero MD, Díaz-Parrado E, Carrión AM, Alfonsi S, Sánchez-Alcazar JA, Bullón P, Battino M, de Miguel M. Is inflammation a mitochondrial dysfunction-dependent event in Fibromyalgia? Antioxid Redox Signal 2013;18:800-7.
12. Cordero MD, Alcocer-Gómez E, Culic O, Carrión AM, de Miguel M, Díaz-Parrado E, Pérez-Villegas EM, Bullón P, Battino M, Sánchez-Alcazar JA. NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 2014;20:1169-80.
13. Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, Ciapparelli A, Dell'Osso L, Bombardieri S. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007;25:225-30.
14. Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ. Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J 2010;3:9-18.
15. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-5.
16. Cotán D, Cordero MD, Garrido-Maraver J, Oropesa-ávila M, Rodríguez-Hernández A, Gómez Izquierdo L, De la Mata M, De Miguel M, Lorite JB, Infante ER, Jackson S, Navas P, Sánchez-Alcázar JA. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J 2011;25:2669-87.
17. De la Mata M, Garrido-Maraver J, Cotán D, Cordero MD, Oropesa-ávila M, Izquierdo LG, De Miguel M, Lorite JB, Infante ER, Ybot P, Jackson S, Sánchez-Alcázar JA. Recovery of MERRF fibroblasts and cybrids pathophysiology by coenzyme Q10. Neurotherapeutics 2012;9:446-63.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988;16:1215.
19. Boyle JS, Lew AM. An inexpensive alternative to glassmilk for DNA purification. Trends Genet 1995;11:8.
20. Bonfield JK, Rada C, Staden R. Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res 1998;26:3404-9.
21. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
24. Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 2014;42(Web Server issue):W252-8.
25. Wheeler TJ, Clements J, Finn RD. Skylign: a tool for creating informative, interactive logos representing sequence alignments and profile hidden Markov models. BMC Bioinformatics 2014;15:7.
26. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T, Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012;36:401-14.
27. Ding Z, Liu S, Wang X, Theus S, Fan Y, Deng X, Mehta JL. LOX-1-dependent mitochondrial DNA damage and NLRP3 activation during systemic inflammation in mice. Biochem Biophys Res Commun 2014;451:637-43.
28. Marchetti C, Chojnacki J, Toldo S, Mezzaroma E, Tranchida N, Rose SW, Federici M, Van Tassell BW, Zhang S, Abbate A. A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse. J Cardiovasc Pharmacol 2014;63:316-22.
29. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989;246:500-3.
30. Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 2010;16:183-8.
31. Hargreaves IP. Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol 2014;49:105-11.
32. Chen Z, Zhao Z, Ye Q, Chen Y, Pan X, Sun B, Huang H, Zheng A. Mild clinical manifestation and unusual recovery upon coenzyme Q10 treatment in the first Chinese Leigh syndrome pedigree with mutation m.10197 G>A. Mol Med Rep 2015;11:1956-62.
33. Roos S, Lindgren U, Ehrstedt C, Moslemi AR, Oldfors A. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations. Neuromuscul Disord 2014;24:713-20.
34. Cordero MD, Cotán D, del-Pozo-Martín Y, Carrión AM, de Miguel M, Bullón P, Sánchez-Alcazar JA. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition 2012;28:1200-3.
35. Mkaouar-Rebai E, Ellouze E, Chamkha I, Kammoun F, Triki C, Fakhfakh F. Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene. J Child Neurol 2011;26:12-20.
36. Watson NF, Buchwald D, Goldberg J, Noonan C, Ellenbogen RG. Neurologic signs and symptoms in fibromyalgia. Arthritis Rheum 2009;60:2839-44.
37. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr. Family study of fibromyalgia. Arthritis Rheum 2004;50:944-52.
38. Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996;26:605-11.
39. Lanciano P, Khalfaoui-Hassani B, Selamoglu N, Ghelli A, Rugolo M, Daldal F. Molecular mechanisms of superoxide production by complex III: a bacterial versus human mitochondrial comparative case study. Biochim Biophys Acta 2013;1827:1332-9.
40. Pongratz DE, Späth M. Morphologic aspects of fibromyalgia. Z Rheumatol 1998;57:47-51.
41. Kalyan-Raman UP, Kalyan-Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol 1984;11:808-13.
42. Yunus MB, Kalyan-Raman UP, Kalyan-Raman K, Masi AT. Pathologic changes in muscle in primary fibromyalgia syndrome. Am J Med 1986;81:38-42.
43. Alcocer-Gómez E, Garrido-Maraver J, Bullón P, Marín-Aguilar F, Cotán D, Carrión AM, Alvarez-Suarez JM, Giampieri F, Sánchez-Alcazar JA, Battino M, Cordero MD. Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from fibromyalgia patients. Biochim Biophys Acta 2015;1852:1257-67.
44. Arpa J, Cruz-Martínez A, Campos Y, Gutiérrez-Molina M, García-Rio F, Pérez-Conde C, Martín MA, Rubio JC, Del Hoyo P, Arpa-Fernández A, Arenas J. Prevalence and progression of mitochondrial diseases: a study of 50 patients. Muscle Nerve 2003;28:690-5.
45. van de Glind G, de Vries M, Rodenburg R, Hol F, Smeitink J, Morava E. Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation. Eur J Paediatr Neurol 2007;11:243-6.
46. Villanova M, Selvi E, Malandrini A, Casali C, Santorelli FM, De Stefano R, Marcolongo R. Mitochondrial myopathy mimicking fibromyalgia syndrome. Muscle Nerve 1999;22:289-91.
47. Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011;166:1-15.
48. Vattemi G, Marini M, Ferreri NR, Hao S, Malatesta M, Meneguzzi A, Guglielmi V, Fava C, Minuz P, Tomelleri G. Overexpression of TNF-a in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria. Free Radic Biol Med 2013;63:108-14.
49. Mancuso M, Orsucci D, Ienco EC, Ricci G, Ali G, Servadio A, Fontanini G, Filosto M, Vielmi V, Rocchi A, Petrozzi L, Logerfo A, Siciliano G. An "inflammatory" mitochondrial myopathy. A case report. Neuromuscul Disord 2013;23:907-10.
50. Gómez-Durán A, Pacheu-Grau D, López-Gallardo E, Díez-Sánchez C, Montoya J, López-Pérez MJ, Ruiz-Pesini E. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 2010;19:3343-53.
51. Benetti E, Chiazza F, Patel NS, Collino M. The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm 2013;2013:678627.
52. Takahashi M. NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J 2014;55:101-5.
53. Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 2014;5:352.
54. Scarpelli M, Cotelli MS, Mancuso M, Tomelleri G, Tonin P, Baronchelli C, Vielmi V, Gregorelli V, Todeschini A, Padovani A, Filosto M. Current options in the treatment of mitochondrial diseases. Recent Pat CNS Drug Discov 2010;5:203-9.
55. Dashdorj A, Jyothi KR, Lim S, Jo A, Nguyen MN, Ha J, Yoon KS, Kim HJ, Park JH, Murphy MP, Kim SS. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines. BMC Med 2013;11:178.
56. Montini G, Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 2008;358:2849-50.